Surv BioPharma Inc.
PrivateLast Round
Series B
Extension
Dec 23, 2025
Total Funding Raised
$38.69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Surv BioPharma Inc. is a biopharmaceutical company that develops oncolytic viruses and in vivo gene therapies for cancers and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surv BioPharma Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Surv BioPharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 23, 2025 | ||||
| Grant | Dec 4, 2025 | ||||
| Series B | Nov 11, 2025 | ||||
| Seed | Dec 28, 2022 |
Surv BioPharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Tokai Tokyo Investment Co., Ltd. | Series B |
| Keio Innovation Initiative | Series B |
| Oita Venture Capital Co., Ltd. | Series B Extension |
| 日本ベンチャーキャピタル株式会社 | Series B |
| Kagoshima Development Co., Ltd. | Seed, Series B |
| 株式会社FFGベンチャービジネスパートナーズ | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
$4.3M round with participation from TOHO HOLDINGS.
- Dec 4, 2025
$17.3M grant from Japan Agency for Medical Research and Development.
Surv BioPharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surv BioPharma Inc.'s valuation, stock price, and market status.